Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

medtech

  • Home
  •  
  • medtech



  • Most Read
  • Latest Comments
  • This $22 million company is changing the future of surgery
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • This $22 million company is changing the future of surgery
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • This $22 million company is changing the future of surgery
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • This $22 million company is changing the future of surgery
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • This $22 million company is changing the future of surgery
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    • News

  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • This $22 million company is changing the future of surgery
    • News

    This $22 million company is changing the future of surgery

    The first evidence of surgery, if you can call it that, dates back to the Neolithic and pre-Classical periods where skull trephining took place. The gruesome practice of cutting small holes in the head was thought to rid the body of spirits and was widely practised throughout Europe, Africa and South America. The Egyptians even

    Read More
    Public
  • PainChek expands across New Zealand with pain tech deployed to 24 aged care facilities
    • News

    PainChek expands across New Zealand with pain tech deployed to 24 aged care facilities

    Confident in their technology that can accurately assess a patient’s pain simply from a short video of their face, medtech company PainChek (ASX: PCK) has successfully converted a 6-month trial with one of New Zealand’s largest aged care operators into a full revenue-generating contract. The contract comes after Summerset Holdings (ASX: SNZ) trialled PainChek’s smartphone

    Read More
    Public
  • Why pigs on this remote Auckland island may be the key to treating Parkinson’s disease
    • News

    Why pigs on this remote Auckland island may be the key to treating Parkinson’s disease

    Of all the places in the world where you thought a cure for Parkinson’s disease might be found, the remote sub-Antarctic Auckland Islands might not have been your first choice but that’s exactly where biotech company Living Cell Technologies (ASX: LCT) will obtain tissue for their clinical trials.  Specifically, Living Cell Technologies has secured a

    Read More
    Public
  • Promising results emerge for HeraMED’s telehealth solution for antenatal care
    • News

    Promising results emerge for HeraMED’s telehealth solution for antenatal care

    With the rapid acceleration of telehealth solutions brought about by the pandemic, one company is uniquely servicing a key demographic- expectant mothers. Medtech HeraMED (ASX: HMD) is moving obstetric care into 2021 with their comprehensive digital health platform, HeraCARE and associated fetal and maternal heart rate monitor, HeraBEAT. The clinically validated tech allows for remote

    Read More
    Public
  • Body of evidence grows for Cynata’s stem cell production platform
    • News

    Body of evidence grows for Cynata’s stem cell production platform

    “Published” is an accolade that many scientists strive for. Showcasing your work and communicating your results to peers feels good, regardless of age.  The setting of scientific show and tell is within scientific journals, offering an enduring record of a scientist’s findings and impact on the world (vastly less obtrusive than being sat down and

    Read More
    Public
  • ImpediMed receives FDA designation for dialysis device
    • News

    ImpediMed receives FDA designation for dialysis device

    From the cochlear implant to pacemakers, medical devices have changed the way we treat and manage numerous conditions. Medtech company ImpediMed (ASX: IPD) saw a need in dialysis patients and sought to offer a better solution. Dialysis is the process of removal of water and waste products from the body to filter out toxins, and

    Read More
    Public
  • «
  • ‹
  • 5
  • 6
  • 7
  • 8
  • 9
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.